Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Amgen Inc.    AMGN

AMGEN INC.

(AMGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths
  • Share prices are approaching a strong support area in daily data, which offers good timing for investors.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
  • Historically, the company has been releasing figures that are above expectations.
Weaknesses
  • The company's enterprise value to sales, at 5.93 times its current sales, is high.
Ratings chart
Sector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
AMGEN INC.-5.87%132 100
JOHNSON & JOHNSON2.15%392 249
ROCHE HOLDING AG-4.55%287 762
PFIZER, INC.8.00%222 836
NOVARTIS AG-11.95%206 585
MERCK & CO., INC.-10.45%206 071
ABBVIE INC.18.30%184 916
NOVO NORDISK A/S6.78%155 973
BRISTOL-MYERS SQUIBB COMPAN..-3.13%139 607
ASTRAZENECA PLC1.60%136 826
ELI LILLY AND COMPANY9.65%130 647
SANOFI-7.35%126 752
GLAXOSMITHKLINE PLC-22.72%92 316
CHUGAI PHARMACEUTICAL CO., ..47.95%78 704
JIANGSU HENGRUI MEDICINE CO..23.39%72 683
DAIICHI SANKYO COMPANY, LIM..45.72%65 583
More Results
Financials (USD)
Sales 2020 25 380 M - -
Net income 2020 7 038 M - -
Net Debt 2020 18 313 M - -
P/E ratio 2020 19,2x
Yield 2020 2,81%
Capitalization 132 B 132 B -
EV / Sales 2020 5,93x
EV / Sales 2021 5,55x
Nbr of Employees 23 400
Free-Float 99,8%
Upcoming event on AMGEN INC.
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes